Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1975 Apr;2(2):159-64.
doi: 10.1111/j.1365-2125.1975.tb01571.x.

Beta-adrenergic receptor blocking drugs, hypertension and plasma renin

Clinical Trial

Beta-adrenergic receptor blocking drugs, hypertension and plasma renin

T O Morgan et al. Br J Clin Pharmacol. 1975 Apr.

Abstract

1 Propranolol and pindolol reduced both the blood pressure and plasma renin activity when given chronically to hypertensive patients. 2 There was no correlation between the fall in blood pressure and the fall in plasma renin activity. 3 Neither the basal nor the random plasma renin activity predicted the patients who would respond to beta-adrenergic receptor blocking drugs. 4 Oral propranolol reduced plasma renin activity but did not reduce blood pressure within 4 h of administration; oral pindolol reduced blood pressure but did not reduce plasma renin activity within 4 h of administration. 5 The reduction of blood pressure by propranolol and pindolol does not seem to be mediated by changes in plasma renin in most patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1972 Mar 2;286(9):441-9 - PubMed
    1. J Clin Endocrinol Metab. 1972 Feb;34(2):386-94 - PubMed
    1. Br Med J. 1969 Jan 4;1(5635):7-16 - PubMed
    1. Circ Res. 1972 Sep;31(9):Suppl 2:203-13 - PubMed
    1. N Engl J Med. 1972 Dec 14;287(24):1209-14 - PubMed

LinkOut - more resources